Cohort study analyzes prescription fills and out-of-pocket costs for glucagon-like peptide-1 receptor agonists, indicating disparities by race and indication.
This cohort study examines how often glucagon-like peptide-1 receptor agonist orders are filled, the out-of-pocket cost per prescription, and differences by patient race and ethnicity or indication among patients with insurance.
No takes yet. Share an insight, caveat, or question.
Sarpatwari et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: